NRAS G12C + BRAF mutation
|
Melanoma
|
NRAS G12C + BRAF mutation
|
Melanoma
|
vemurafenib Resistant: D – Preclinical
|
vemurafenib Resistant: D – Preclinical
|
NRAS G12C + BRAF mutation
|
CRC
|
NRAS G12C + BRAF mutation
|
CRC
|
trametinib Resistant: D – Preclinical
|
trametinib Resistant: D – Preclinical
|